Susan Escudier, MD

Associate Professor of Clinical Medicine, Institute for Academic Medicine
Houston Methodist

Education & Training

MD, Baylor College of Medicine
Residency, Baylor College of Medicine
Clinical Fellowship, The University of Texas MD Anderson Cancer Center

Symptomatic cryofibrinogenemia following trauma
Chamberlain, PD, Huttenbach, Y & Escudier, SM 2017, Journal of Clinical Rheumatology, vol 23, no. 8, pp. 449-450. DOI: 10.1097/RHU.0000000000000590

Cetuximab-associated elongation of the eyelashes: Case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors
Cohen, PR, Escudier, SM & Kurzrock, R 2011, American Journal of Clinical Dermatology, vol 12, no. 1, pp. 63-67. DOI: 10.2165/11531920-000000000-00000

Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid
Escudier, SM, Kantarjian, HM & Estey, EH 1996, Leukemia and Lymphoma, vol 20, no. 5-6, pp. 435-439.

Acute lymphoblastic leukemia following preleukemic syndromes in adults
Escudier, SM, Albitar, M, Robertson, LE, Andreeff, M, Pierce, S & Kantarjian, HM 1996, Leukemia, vol 10, no. 3, pp. 473-477.

High incidence of monosomy 18 in lymphoid malignancies that have bone marrow and peripheral blood involvement
Younes, A, Jendiroba, D, Engel, H, Escudier, S, Katz, R, Rodriguez, MA, Hill, D, Cabanillas, F & Andreeff, M 1994, Cancer Genetics and Cytogenetics, vol 77, no. 1, pp. 39-44.

Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: Comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor
Estey, E, Thall, P, Andreeff, M, Beran, M, Kantarjian, H, OBrien, S, Escudier, S, Robertson, LE, Koller, C, Kornblau, S, Pierce, S, Freireich, EJ, Deisseroth, A & Keating, M 1994, Journal of Clinical Oncology, vol 12, no. 4, pp. 671-678.

Hematologic malignancies and pregnancy
Escudier, SM & Keating, MJ 1994, Cancer Bulletin, vol 46, no. 5, pp. 418-423.

Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation
Przepiorka, D, Ippoliti, C, Koberda, J, Chan, KW, Khouri, IF, Fischer, HE, Huh, YO, Escudier, SM, Seong, D, Davis, M, Gajewski, J, Vriesendorp, HM & Champlin, RE 1994, Transplantation, vol 58, no. 7, pp. 858-860.

Acute leukemia complicating bone marrow hypoplasia in an adult with Shwachman's syndrome
Seymour, JF & Escudier, SM 1993, Leukemia and Lymphoma, vol 12, no. 1-2, pp. 131-135.

Treatment of myelodysplastic syndromes with AML-Type chemotherapy
Estey, E, Pierce, S, Kantarjian, H, OBrien, S, Beran, M, Andreeff, M, Escudier, S, Koller, C, Kornblau, S, Robertson, L & Keating, M 1993, Leukemia and Lymphoma, vol 11, no. SUPPL. 2, pp. 59-63.

Use of retroviral markers to identify efficacy of purging and origin of relapse following autologous bone marrow and peripheral blood cell transplantation in indolent B cell neoplasms (follicular non-Hodgkin's lymphoma or chronic lymphocytic leukemia (CLL) patients)
Deisseroth, A, Kantarjian, H, Champlin, R, Cabanillas, F, Keating, M, Reading, C, Andersson, B, Claxton, D, Robertson, B, Escudier, S, Andreeff, M, OBrien, S, Kornblau, S, Ellerson, D, Hanania, E & Fe, S 1993, Human Gene Therapy, vol 4, no. 6, pp. 821-834.

Preliminary results of treatment with filgrastim for relapse of leukemia and myelodysplasia after allogeneic bone marrow transplantation
Giralt, S, Escudier, S, Kantarjian, H, Deisseroth, A, Freireich, EJ, Andersson, BS, OBrien, S, Andreeff, M, Fisher, H, Cork, A, Hirsch-Ginsberg, C, Trujillo, J, Stass, S & Champlin, RE 1993, New England Journal of Medicine, vol 329, no. 11, pp. 757-761.

Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemia
Escudier, SM, Pereira-Leahy, JM, Drach, JW, Weier, HU, Goodacre, AM, Cork, MA, Trujillo, JM, Keating, MJ & Andreeff, M 1993, Blood, vol 81, no. 10, pp. 2702-2707.

Treatment of Newly-Diagnosed AML with Idarubicin + ARA-C
Estey, E, Kantarjian, H, OBRIEN, S, Feldman, E, Roller, C, Beran, M, Andreeff, M, Escudier, S, Kornblau, S & Keating, M 1992, Leukemia and Lymphoma, vol 7, no. sup2, pp. 121. DOI: 10.3109/10428199209058686

Treatment of Newly-Diagnosed AML with idarubicin + ARA-C
Estey, E, Kantajian, H, OBrien, S, Feldman, E, Koller, C, Beran, M, Andreeff, M, Escudier, S, Kornblau, S & Keating, M 1992, Leukemia and Lymphoma, vol 7, no. SUPPL. 2.

Pathologic findings in the hearts of patients with acquired immunodeficiency syndrome
Klima, M & Escudier, SM 1991, Texas Heart Institute Journal, vol 18, no. 2, pp. 116-121.

Carcinoma-associated hemolytic uremic syndrome in patients with genitourinary malignancies
Escudier, SM & Amato, RJ 1991, Cancer Bulletin, vol 43, no. 4, pp. 362-365.